These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17377162)

  • 21. Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study.
    Schindler C; Mueller A; Bramlage P; Boecking W; Kirch W; Schweizer J
    Angiology; 2007 Dec-2008 Jan; 58(6):710-6. PubMed ID: 17928625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral arterial disease. Are your legs at risk?
    Mayo Clin Health Lett; 2004 Mar; 22(3):1-3. PubMed ID: 15000063
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological interventions for peripheral artery disease.
    Duprez DA
    Expert Opin Pharmacother; 2007 Jul; 8(10):1465-77. PubMed ID: 17661729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The EXercise versus Angioplasty in Claudication Trial (EXACT): reasons for recruitment failure and the implications for research into and treatment of intermittent claudication.
    Hobbs SD; Bradbury AW
    J Vasc Surg; 2006 Aug; 44(2):432-3. PubMed ID: 16890883
    [No Abstract]   [Full Text] [Related]  

  • 25. Peripheral arterial disease.
    Hills AJ; Shalhoub J; Shepherd AC; Davies AH
    Br J Hosp Med (Lond); 2009 Oct; 70(10):560-5. PubMed ID: 19966700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consensus document on intermittent claudication from the Central European Vascular Forum 1st edition - Abano Terme (Italy) - May 2005 2nd revision - Portroz (Slovenia) September 2007.
    Andreozzi GM; Arosio E; Martini R; Verlato F; Visonà A
    Int Angiol; 2008 Apr; 27(2):93-113. PubMed ID: 18427396
    [No Abstract]   [Full Text] [Related]  

  • 27. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial.
    Koppensteiner R; Spring S; Amann-Vesti BR; Meier T; Pfammatter T; Rousson V; Banyai M; van der Loo B
    J Vasc Surg; 2006 Dec; 44(6):1247-53. PubMed ID: 17145426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endovascular management of infrainguinal disease.
    Lumsden AB; Das TS
    J Endovasc Ther; 2006 Feb; 13 Suppl 2():II1-2. PubMed ID: 16472012
    [No Abstract]   [Full Text] [Related]  

  • 29. The Baltimore activity scale for intermittent claudication: a validation study.
    Gardner AW; Montgomery PS
    Vasc Endovascular Surg; 2006; 40(5):383-91. PubMed ID: 17038572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endovascular intervention for infrainguinal artery disease requires additional evidence regarding selection of devices.
    Ikeno F
    J Vasc Interv Radiol; 2006 Sep; 17(9):1545. PubMed ID: 16990477
    [No Abstract]   [Full Text] [Related]  

  • 31. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy.
    de Vries SO; Visser K; de Vries JA; Wong JB; Donaldson MC; Hunink MG
    Radiology; 2002 Jan; 222(1):25-36. PubMed ID: 11756701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Definition of the diagnostico-therapeutic procedures in chronic peripheral obstructive arteriopathy. Guidelines of the Italian Society of Angiology and Vascular diseases (SIAPAV)].
    Pedrini L; Spartera C; Ponzio F; Arosio E; Andreozzi GM; Signorelli S; Scondotto G; Stella A; Todini AR; Coppi G; De Donato G; De Fabritiis A; Rosato E; Urbano O;
    Minerva Cardioangiol; 2000 Sep; 48(9):277-302. PubMed ID: 11125527
    [No Abstract]   [Full Text] [Related]  

  • 33. Peripheral arterial insufficiency: mechanisms, natural history, and therapeutic options.
    Rockson SG; Cooke JP
    Adv Intern Med; 1998; 43():253-77. PubMed ID: 9506185
    [No Abstract]   [Full Text] [Related]  

  • 34. Spotlight on claudication: an important disease gets attention.
    Murphy TP; Dubel G; Bass J; Ahn SH; Soares GM; Cerezo J
    Med Health R I; 2007 Feb; 90(2):40-2. PubMed ID: 17500249
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of peripheral arterial disease.
    Aronow WS
    Cardiol Rev; 2005; 13(2):61-8. PubMed ID: 15705252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermittent claudication.
    Dregelid E
    N Engl J Med; 2007 Jul; 357(1):92; author reply 92-3. PubMed ID: 17615642
    [No Abstract]   [Full Text] [Related]  

  • 37. Peripheral vascular disease: walking toward a cure.
    Johns Hopkins Med Lett Health After 50; 2000 Mar; 12(1):3. PubMed ID: 10740442
    [No Abstract]   [Full Text] [Related]  

  • 38. [Intermittent claudication].
    Koraen L; Wahlberg E
    Lakartidningen; 2010 Jul 21-Aug 10; 107(29-31):1774-9. PubMed ID: 20812563
    [No Abstract]   [Full Text] [Related]  

  • 39. Current status of lower-extremity revascularization.
    Friedell ML; Stark KR; Kujath SW; Carter RR
    Curr Probl Surg; 2014 Jun; 51(6):254-90. PubMed ID: 24863077
    [No Abstract]   [Full Text] [Related]  

  • 40. Inter-society consensus for the management of peripheral arterial disease.
    Norgren L; Hiatt WR; Dormandy JA; Nehler MR; Harris KA; Fowkes FG; Rutherford RB;
    Int Angiol; 2007 Jun; 26(2):81-157. PubMed ID: 17489079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.